1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
Main Authors: | Kun-Hsing Yu, Shadmehr Demehri, Nga Nguyen, Leyre Zubiri, Kerry Reynolds, Alexander Gusev, Shawn Kwatra, Yevgeniy R Semenov, Nicole R LeBoeuf, Jayhyun Seo, William Lotter, Katie Roster, Wenxin Chen, Guihong Wan, Ahmad Rajesh, Hannah Rashdan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
1251 Seasonal and geographic patterns in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors: a multicenter analysis
by: Kerry Reynolds, et al.
Published: (2023-11-01) -
1273 Effect of systemic immunosuppression timing on overall survival among immune checkpoint inhibitor recipients
by: Kun-Hsing Yu, et al.
Published: (2023-11-01) -
804 Real-world incidence and impact of pneumonitis in lung cancer patients treated with immune checkpoint inhibitors
by: Ryan Sullivan, et al.
Published: (2021-11-01) -
Profiling the 'Triple Crusade', c.1233-c.1241
by: Reddish, H
Published: (2022) -
Food and drug administration approval process for dermatology drugs in the United States
by: Emily Boozalis, et al.
Published: (2018-08-01)